Clinical Laserthermia Systems AB (publ) carries out a directed issue of shares to set-off debt following a request for loan conversion by lenders
Lund, Sweden – Clinical Laserthermia Systems AB’s (“CLS” or the “Company”) has today, with the support of the authorization from the extra general meeting held on 22 November 2022, resolved on a directed share issue of 4,846,524 B-shares (the “Issue”) to Modelio Equity AB, Lubrica Equity AB and Formue Nord Fokus A/S (the “Lenders”) upon a request for conversion of debt totalling SEK 3 million. The subscription price in the Issue is determined to SEK 0.6190 per new B-share, payment will be made by offsetting the claim against the Company, consisting of the Lenders respective loan amounts.CLS